Form D · Biotechnology
QUANTBIOME INC.
San Jose, CA · CIK 0001691552
Offering snapshot reported Dec 8, 2016 · SEC filing
- Reported sold
- $450K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 22, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 8, 2016 | Initial | $450,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-275855
Simple Agreement for Future Equity (SAFE).
Source: Form D, filed Dec 8, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daphne Carmeli | Director |
| Tim Connors | Director |
| Sang Han | Director, Executive |
| Richard Lin | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
330 Bautista Pl.
San Jose, CA, 95126
San Jose, CA, 95126